Targeted Therapy Larotrectinib Shows Promise in Early Trials, Regardless of Cancer Type

Initial results from a series of three small clinical trials of a targeted cancer therapy called larotrectinib suggest that it may be effective in patients—children and adults—with a wide variety of cancer types.

Cancer Currents: An NCI Cancer Research Blog